Danish company Samplix ApS selected Innokas Medical to co-create the novel Xdrop™ instrument for droplet-based PCR-free enrichment of genomic regions.
Recent Posts
#GivingTuesday is a global day when the world comes together to give.
Innokas Medical and Serres together support children in specialized medical care, and their families
In addition to co-creating the future of healthcare together, Innokas Medical and Serres have decided to bring their cooperation in the next level by becoming corporate partners of important...
Serres Saga® Fluid Management System, co-created by Serres Oy and Innokas Medical, is a smart solution for managing large fluid volumes in the operating rooms, improving efficiency, safety and...
There’s a few common trends in the medical field, which have a clear effect to the development of new medical products. The first one is the constantly changing jungle of rules and regulations,...
MedTech as business is changing and getting more complex. For example, the technical complexity and regulatory requirements are something that are increasing as we speak. In addition, the user...
We’re living in an amazing world where the new technologies and the science itself enable new kinds of miracles happen in saving peoples’ lives and in improving their well-being. In recent years,...
Innokas Medical and BusinessOulu/OuluHealth are arranging Health Business Breakfast event in Oulu in the middle of June. Welcome to listen, discuss and network with the professionals in the field!
MedTech as a business is changing and getting more diverse. For example, the technical complexity, forms of digitization and regulatory requirements are something that are increasing as we speak....
MedTech as business is changing and getting more complex. For example, the technical complexity and regulatory requirements are something that are increasing as we speak. At the same time there is...
